Beecham Recalls Requip® Tablets
August 4, 1999
Philadelphia, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that SmithKline Beecham Pharmaceuticals is recalling
Requip® Tablets because the tablet fades from pale blue to white.
Requip® Tablets (Ropinirole HCl), 5 mg, in 100
tablet bottles, Rx taken orally for the treatment of Parkinson's disease. NDC
Lot Numbers: 680930 EXP 4/30/99, 680940 EXP 7/31/99,720510 EXP 11/30/99.
SmithKline Beecham Pharmaceuticals, Crawlely, West Sussex.
SmithKline Beecham Pharmaceuticals, Philadelphia, Pennsylvania, by letter sent on
March 3, 1999, and June 4, 1999. Firm-initiated recall ongoing.
Approximately 14,033 bottles remained on market at time of recall initiation.